Vertex Pharmaceuticals Incorporated

329,99 USD -2,64 (-0,79%)
Bid 325,43 USD
Ask 334,50 USD

Premiumpartner

Firmenbeschreibung

Vertex Pharmaceuticals Inc. ist ein globales Biotech-Unternehmen, das sich der Entdeckung und Entwicklung kleinmolekularer Arzneimittel zur Behandlung von schweren Erkrankungen verschrieben hat. Die Strategie des Unternehmens besteht aus der Vermarktung seiner Produkte sowohl unabhängig als auch gemeinsam mit führenden Pharmakonzernen. Die Produktpipeline von Vertex ist hauptsächlich auf Virusinfektionen, Entzündungen, Autoimmunkrankheiten und Krebs ausgerichtet. Vertex vermarktet den HIV-Proteasehemmer Lexiva gemeinsam mit GlaxoSmithKline.

KeyData

endOfFinancialYear: 31.12.2022 01:00
stockholderStructure: Freefloat (82.7%),BlackRock, Inc. (9.4%),The Vanguard Group (7.9%)
sharesOutstanding: 257551600.0000
ceo: Reshma Kewalramani, M.D.
board: Charles F. Wagner, Jr., Amit K. Sachdev, Bastiano Sanna, Ph.D., Carmen Bozic, M.D., Damian Wimot, Dr. David Altshuler, Dr. Jeffrey Leiden, Joy Liu, Ludovic Fenaux, Mark Bunnage, Michael Partridge, Mike Tirozzi, Nia Tatsis, Ph.D., Nina Devlin, Paul Negulescu, Stephanie Franklin, Stuart A. Arbuckle
supervisoryBoard: Dr. Jeffrey Leiden, Bruce I. Sachs, Diana McKenzie, Dr. Alan Garber, Dr. Sangeeta N. Bhatia, Lloyd Carney, Margaret McGlynn, Reshma Kewalramani, Terrence C. Kearney, Yuchun Lee
countryID: 20
freeFloat: 82.7000
faceValue: 0.0100
faceValueCurrencyID: 4
faceValueCurrency: USD
sectorName: Pharmazeutische Industrie
industryName: Gesundheitswesen
subsectorName: Pharmazeutische Industrie
country: USA
countryName: USA

Kontakt

name: Michael Partridge
phone: +1-617-444-0585
email: investorinfo@vrtx.com
irWebSite: https://investors.vrtx.com/

Adresse

street: 50 Northern Avenue
city: Boston, Massachusetts 02210, USA
phone: +1-617-341-6100
webSite: www.vrtx.com/

Finanzen (kurz)

year: 2020 cash: 5988.1870
balanceSheetTotal: 11751.8080 liabilities: 3064.9930
totalShareholdersEquity: 8686.8150 sales: 6205.6830
investment: 22.2000 incomeBeforeTaxes: 3116.7980
netIncome: 2711.6470 cashFlow: 2868.1640
employees: 3400 currencyID: 4
units: 1000000 currency: USD
year: 2021 cash: 6795.0000
balanceSheetTotal: 13432.5000 liabilities: 3332.5000
totalShareholdersEquity: 10100.0000 sales: 7574.4000
investment: 4.9000 incomeBeforeTaxes: 2730.4000
netIncome: 2342.1000 cashFlow: 811.2000
employees: 3900 currencyID: 4
units: 1000000 currency: USD
year: 2022 cash: 10504.0000
balanceSheetTotal: 18150.9000 liabilities: 4238.2000
totalShareholdersEquity: 13912.7000 sales: 8930.7000
incomeBeforeTaxes: 4232.4000 netIncome: 3322.0000
cashFlow: 3711.9000 currencyID: 4
units: 1000000 currency: USD

Finanzen (kurz)

year: 2020
cash: 5988.1870
balanceSheetTotal: 11751.8080
liabilities: 3064.9930
totalShareholdersEquity: 8686.8150
sales: 6205.6830
investment: 22.2000
incomeBeforeTaxes: 3116.7980
netIncome: 2711.6470
cashFlow: 2868.1640
employees: 3400
currencyID: 4
units: 1000000
currency: USD
year: 2021
cash: 6795.0000
balanceSheetTotal: 13432.5000
liabilities: 3332.5000
totalShareholdersEquity: 10100.0000
sales: 7574.4000
investment: 4.9000
incomeBeforeTaxes: 2730.4000
netIncome: 2342.1000
cashFlow: 811.2000
employees: 3900
currencyID: 4
units: 1000000
currency: USD
year: 2022
cash: 10504.0000
balanceSheetTotal: 18150.9000
liabilities: 4238.2000
totalShareholdersEquity: 13912.7000
sales: 8930.7000
incomeBeforeTaxes: 4232.4000
netIncome: 3322.0000
cashFlow: 3711.9000
currencyID: 4
units: 1000000
currency: USD

Finanzen (ausführlich)

year: 2021 units: 1000000
balanceSheetTotal: 13432.5000 cash: 6795.0000
currentAssets: 9560.6000 fixedAssets: 3871.9000
liabilities: 2142.0000 totalLiabilitiesEquity: 13432.5000
totalShareholdersEquity: 10100.0000 employees: 3900
property: 1094.1000 inventories: 353.1000
accountsReceivable: 1136.8000 currentSecurities: 729.9000
accountsPayable: 195.0000 liabilitiesBanks: 0.0000
liabilitiesTotal: 3332.5000 longTermDebt: 509.8000
shortTermDebt: 0.0000 sales: 7574.4000
netIncome: 2342.1000 operatingResult: 2782.1000
incomeInterest: 61.5000 investments: 3051.1000
incomeTaxes: 388.3000 costGoodsSold: 904.2000
grossProfit: 6670.2000 revenuePerEmployee: 1942153.8462
cashFlow: 2643.5000 cashFlowInvesting: -340.9000
cashFlowFinancing: -1478.0000 cashFlowTotal: 811.2000
accountingStandard: US GAAP equityRatio: 75.1908
debtEquityRatio: 32.9950 liquidityI: 351.3025
liquidityII: 404.3744 netMargin: 30.9213
grossMargin: 88.0624 cashFlowMargin: 34.9005
ebitMargin: 36.7303 ebitdaMargin: 0.0000
preTaxROE: 27.0337 preTaxROA: 20.3268
roe: 23.1891 roa: 17.4361
netIncomeGrowth: -13.6281 revenuesGrowth: 22.0559
taxExpenseRate: 14.2214 equityTurnover: 0.7499
epsBasic: 9.0900 epsDiluted: 9.0100
epsBasicGrowth: -12.9310 incomeBeforeTaxes: 2730.4000
priceEarningsRatioCompany: 24.1584 priceCashFlowRatio: 21.1481
bookValuePerShare: 39.6737 marketCap: 55905041343.6000
earningsYield: 4.1393 pegRatio: -1.8683
cashFlowPerShare: 10.3839 priceBookValueRatio: 5.5352
priceEarningsRatio: 23.8696 netEarningsPerShare: 9.2000
currency: USD
year: 2022 units: 1000000
balanceSheetTotal: 18150.9000 cash: 10504.0000
currentAssets: 13234.8000 fixedAssets: 4916.1000
liabilities: 2742.1000 totalLiabilitiesEquity: 18150.9000
totalShareholdersEquity: 13912.7000 property: 1108.4000
inventories: 460.6000 accountsReceivable: 1442.2000
accountsPayable: 303.9000 liabilitiesTotal: 4238.2000
longTermDebt: 430.8000 shortTermDebt: 0.0000
sales: 8930.7000 netIncome: 3322.0000
operatingResult: 4307.4000 incomeInterest: 54.8000
investments: 2540.3000 incomeTaxes: 910.4000
costGoodsSold: 1080.3000 grossProfit: 7850.4000
cashFlow: 4129.9000 cashFlowInvesting: -321.1000
cashFlowFinancing: -67.7000 cashFlowTotal: 3711.9000
accountingStandard: US GAAP equityRatio: 76.6502
debtEquityRatio: 30.4628 liquidityI: 383.0641
liquidityII: 435.6588 netMargin: 37.1975
grossMargin: 87.9035 cashFlowMargin: 46.2439
ebitMargin: 48.2314 ebitdaMargin: 0.0000
preTaxROE: 30.4211 preTaxROA: 23.3179
roe: 23.8775 roa: 18.3021
netIncomeGrowth: 41.8385 revenuesGrowth: 17.9064
taxExpenseRate: 21.5103 equityTurnover: 0.6419
epsBasic: 12.9700 epsDiluted: 12.8200
epsBasicGrowth: 42.6843 incomeBeforeTaxes: 4232.4000
priceEarningsRatioCompany: 22.2652 priceCashFlowRatio: 17.9769
bookValuePerShare: 54.1158 marketCap: 74242866331.9800
earningsYield: 4.4913 pegRatio: 0.5216
cashFlowPerShare: 16.0639 priceBookValueRatio: 5.3363
priceEarningsRatio: 22.3488 netEarningsPerShare: 12.9215
currency: USD
year: 2023 priceEarningsRatioCompany: 25.4426
priceCashFlowRatio: 20.5423 bookValuePerShare: 54.1158
marketCap: 84989452484.0000 earningsYield: 3.9304
pegRatio: 0.5961 cashFlowPerShare: 16.0639
netAssetsPerShare: 54.1158 priceBookValueRatio: 6.0979
priceEarningsRatio: 25.5381 netEarningsPerShare: 12.9215
currency: USD

Finanzen (ausführlich)

year: 2021
units: 1000000
balanceSheetTotal: 13432.5000
cash: 6795.0000
currentAssets: 9560.6000
fixedAssets: 3871.9000
liabilities: 2142.0000
totalLiabilitiesEquity: 13432.5000
totalShareholdersEquity: 10100.0000
employees: 3900
property: 1094.1000
inventories: 353.1000
accountsReceivable: 1136.8000
currentSecurities: 729.9000
accountsPayable: 195.0000
liabilitiesBanks: 0.0000
liabilitiesTotal: 3332.5000
longTermDebt: 509.8000
shortTermDebt: 0.0000
sales: 7574.4000
netIncome: 2342.1000
operatingResult: 2782.1000
incomeInterest: 61.5000
investments: 3051.1000
incomeTaxes: 388.3000
costGoodsSold: 904.2000
grossProfit: 6670.2000
revenuePerEmployee: 1942153.8462
cashFlow: 2643.5000
cashFlowInvesting: -340.9000
cashFlowFinancing: -1478.0000
cashFlowTotal: 811.2000
accountingStandard: US GAAP
equityRatio: 75.1908
debtEquityRatio: 32.9950
liquidityI: 351.3025
liquidityII: 404.3744
netMargin: 30.9213
grossMargin: 88.0624
cashFlowMargin: 34.9005
ebitMargin: 36.7303
ebitdaMargin: 0.0000
preTaxROE: 27.0337
preTaxROA: 20.3268
roe: 23.1891
roa: 17.4361
netIncomeGrowth: -13.6281
revenuesGrowth: 22.0559
taxExpenseRate: 14.2214
equityTurnover: 0.7499
epsBasic: 9.0900
epsDiluted: 9.0100
epsBasicGrowth: -12.9310
incomeBeforeTaxes: 2730.4000
priceEarningsRatioCompany: 24.1584
priceCashFlowRatio: 21.1481
bookValuePerShare: 39.6737
marketCap: 55905041343.6000
earningsYield: 4.1393
pegRatio: -1.8683
cashFlowPerShare: 10.3839
priceBookValueRatio: 5.5352
priceEarningsRatio: 23.8696
netEarningsPerShare: 9.2000
currency: USD
year: 2022
units: 1000000
balanceSheetTotal: 18150.9000
cash: 10504.0000
currentAssets: 13234.8000
fixedAssets: 4916.1000
liabilities: 2742.1000
totalLiabilitiesEquity: 18150.9000
totalShareholdersEquity: 13912.7000
property: 1108.4000
inventories: 460.6000
accountsReceivable: 1442.2000
accountsPayable: 303.9000
liabilitiesTotal: 4238.2000
longTermDebt: 430.8000
shortTermDebt: 0.0000
sales: 8930.7000
netIncome: 3322.0000
operatingResult: 4307.4000
incomeInterest: 54.8000
investments: 2540.3000
incomeTaxes: 910.4000
costGoodsSold: 1080.3000
grossProfit: 7850.4000
cashFlow: 4129.9000
cashFlowInvesting: -321.1000
cashFlowFinancing: -67.7000
cashFlowTotal: 3711.9000
accountingStandard: US GAAP
equityRatio: 76.6502
debtEquityRatio: 30.4628
liquidityI: 383.0641
liquidityII: 435.6588
netMargin: 37.1975
grossMargin: 87.9035
cashFlowMargin: 46.2439
ebitMargin: 48.2314
ebitdaMargin: 0.0000
preTaxROE: 30.4211
preTaxROA: 23.3179
roe: 23.8775
roa: 18.3021
netIncomeGrowth: 41.8385
revenuesGrowth: 17.9064
taxExpenseRate: 21.5103
equityTurnover: 0.6419
epsBasic: 12.9700
epsDiluted: 12.8200
epsBasicGrowth: 42.6843
incomeBeforeTaxes: 4232.4000
priceEarningsRatioCompany: 22.2652
priceCashFlowRatio: 17.9769
bookValuePerShare: 54.1158
marketCap: 74242866331.9800
earningsYield: 4.4913
pegRatio: 0.5216
cashFlowPerShare: 16.0639
priceBookValueRatio: 5.3363
priceEarningsRatio: 22.3488
netEarningsPerShare: 12.9215
currency: USD
year: 2023
priceEarningsRatioCompany: 25.4426
priceCashFlowRatio: 20.5423
bookValuePerShare: 54.1158
marketCap: 84989452484.0000
earningsYield: 3.9304
pegRatio: 0.5961
cashFlowPerShare: 16.0639
netAssetsPerShare: 54.1158
priceBookValueRatio: 6.0979
priceEarningsRatio: 25.5381
netEarningsPerShare: 12.9215
currency: USD